Proteome Analysis and Immunotherapy for Murine Aspergillosis - Chaturvedi, Ashok
40,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
20 °P sammeln
  • Broschiertes Buch

Aspergillus fumigatus is a pathogenic fungus found in the Ascomycota Phylum. A. fumigatus causes more infections worldwide than any other mould. Four percent of all patients dying in tertiary care hospitals in Europe have invasive aspergillosis. The fungus causes allergic deseases in asthmatics and patients suffering from cystic fibrosis. Invasive aspergillosis can occur in individuals with cavities caused by tuberculosis or other cystic lung diseases. In A. fumigatus, as in other pathogenic fungi, the cell wall is continuosly in contact with the host cells and proteins, and acts as a sieve…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Aspergillus fumigatus is a pathogenic fungus found in the Ascomycota Phylum. A. fumigatus causes more infections worldwide than any other mould. Four percent of all patients dying in tertiary care hospitals in Europe have invasive aspergillosis. The fungus causes allergic deseases in asthmatics and patients suffering from cystic fibrosis. Invasive aspergillosis can occur in individuals with cavities caused by tuberculosis or other cystic lung diseases. In A. fumigatus, as in other pathogenic fungi, the cell wall is continuosly in contact with the host cells and proteins, and acts as a sieve and a reservoir for molecules such as antigens and enzymes having an active role during infection. This includes alteration and modulation of host immune responses. The increase in infection, combined with the reduced efficacy of the currently available drugs, highlights the need for new antifungal drugs and the immunotherapeutics that may suit better. The potential therapeutic application of MAbs created a tremendous interest in the medical and pharmaceutical community.Very few MAbs have been used in immunotherapy against experimental aspergillosis.
Autorenporträt
Ashok K Chaturvedi is a Post-doctoral research associate in The South Texas Center for Emerging Infectious Diseases (STCEID) of The University of Texas at San Antonio. He is a member of American Society for Microbiology. Dr. Chaturvedi has done PhD in 2006 from Central Drug Research Institute (CDRI), Lucknow, India.